Press Release« Back to Press Releases
BioImagene to Hosit Seminar on transformational role of Digital Pathology at USCAP Annual Meeting 2009
Cupertino, CA, February 18, 2009
BioImagene, the leading provider of innovative digital pathology solutions, today announced that the company will host a satellite seminar at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting 2009, which will take place in March in Boston.
The seminar titled Enabling Personalized Medicine through Innovative Digital Pathology will take place on Sunday, March 8, 2009, at Boston’s Hynes Convention Center. It will focus on new technologies poised to revolutionize the practice of pathology, with a specific focus on digital pathology.
Jared Schwartz, MD, Ph.D., President of the College of American Pathologists, will deliver the keynote address in his talk titled Pathology in the Emerging Age of Imaging and Omics.
The featured speakers include:
Keith Kaplan, M.D., Mayo Clinic - Clinical Applications of Digital Pathology and Image Analysis
Mahul Amin, M.D., Chairman, Department of Pathology, Cedars Sinai Medical Center - The Role of the Anatomic Pathologist in the Era of Personalized Medicine: Potential Impact of Enabling Technologies That Will Empower Our Specialty
Ajit Singh, Ph.D., CEO, BioImagene, - Lessons from Digitizing Radiology: The Promise of Digital Pathology
Dr Ajit Singh, CEO BioImagene commented, ”We are privileged to listen to distinguished speakers such as Dr Amin, Dr Kaplan and Dr Schwartz, who are opinion leaders in the field of pathology as well as early adopters of pathology innovations.” Dr Singh continued, “The pathology industry is in the midst of the most dramatic transformation in its more than 80-year history. New technologies have the ability not only to improve pathology processes, but also to open the door to entirely new classes of patient specific treatments. Through this seminar, the audience will gain new insights into the trends and technologies reshaping the pathology industry.”
To register or to receive more information, please visit www.bioimagene.com.
About BioImagene
BioImagene (www.bioimagene.com) is the leader in providing innovative and affordable digital pathology solutions for clinical diagnostics and drug discovery.
BioImagene products are FDA-cleared for specific clinical applications and are intended for research use for other applications.
Media Contact
Andrea tenBroek/Krystin Hayward
781-684-0770
andrea@bioimagene.com